Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
11/5/2024
Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...
11/5/2024
Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval
11/5/2024
AstraZeneca China Updates Leadership and Ownership Structure Amid Inve...
11/5/2024
NMPA Solicits Public Comments on Drug Contract Manufacturing Document
11/5/2024
Aurobindo Challenges China in the Global Penicillin G Market with New ...
11/4/2024
Li Li Meets with Head of Brazil's Health Regulatory Agency
11/4/2024
NMPA Signs Letter of Intent on Cooperation with Danish Medicines Agenc...
11/4/2024
The 10th Round of National Level VBP of Drugs Officially Initiated wit...
11/4/2024
BIOSECURE Act May Shift Biopharma Manufacturing from China to India, S...
11/4/2024
China Targets AstraZeneca in BMI Fraud Probe over Tagrisso
11/4/2024
Saudi FDA Chief Highlights Investment Opportunities for Chinese Cos in...
11/4/2024
NeuroDawn Completes Series C Financing to Advance CNS Drug Pipeline
11/4/2024
US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA
11/4/2024
CureGene Completes Series B+ Financing, Advancing Cardiovascular and A...
11/4/2024
Hangzhou Reprogenix Secures Over CNY 100M in Series A Funding, Advanci...
11/4/2024
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescim...
11/4/2024
HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...
11/4/2024
CARsgen and Galapagos Resume CAR-T Trials Following Regulatory Pauses
11/1/2024
Recent Executive Moves
11/1/2024
NMPA Issues Announcement for Applicability of ICH Guideline M12
11/1/2024
NHC Minister Engages in Video Conference with WHO Director-General
(Free)
11/1/2024
Shanghai Unveils Initiative to Boost Local Biopharma's Global Expansio...
11/1/2024
Global Biotech Supply Chain: A Shift Away from China and Opportunities...
11/1/2024
Merck Faces Gardasil Sales Challenges in China, Impact Expected to Con...
11/1/2024
Hengrui Pharma Weighs Hong Kong IPO to Drive Global Expansion
11/1/2024
U.S. Drugmakers Seek Alternatives to Chinese Supply Chains Amid Rising...
10/31/2024
Biostar Pharma Debutx on the Hong Kong Stock Exchange
10/31/2024
CirCode Advances Gene Therapy with HM2002 IND Approval
10/31/2024
AllianThera's IND for IBD Candidate ATB102 Cleared by the USFDA
10/31/2024
CStone Announces MHRA Approval of Sugemalimab for First-Line NSCLC Tre...
Page:
12
/
42
Total number of articles:
1234
:
[First]
[<<]
[10]
[11]
[12]
[13]
[14]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit